Eye scan study for drug-resistant epilepsy
Part of Brain & nervous system clinical trials.
This study uses a special eye scan (OCT) to look for changes in the retina that might be linked to hard-to-control epilepsy. The goal is to find new biomarkers that could help doctors better understand and manage the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 40 years old
- If you have epilepsy, you've had it for at least 1 year and take seizure medication
- If you have migraine or certain headaches, you must be taking a seizure medication for that condition
- You cannot have had eye surgery, glaucoma, or serious eye problems
- You cannot be taking valproate or vigabatrin (specific seizure drugs)
- You cannot have diabetes, uncontrolled high blood pressure, or major neurological diseases like multiple sclerosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your brain becomes aware of things—like sounds and images—by measuring pupil size and brain activity. Healthy people may have an MRI; epilepsy patients with special brain electrodes already implanted can also join a part of the study.
This trial tests a new type of brain scanner (MEG) to help locate the exact area in the brain causing seizures in people with drug-resistant epilepsy. The goal is to improve planning for surgery to remove that area.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This study looks at how different brain scans (like MRI, PET, and EEG) can help find the exact spot where seizures start in people whose epilepsy hasn't been controlled by medicines. It aims to better understand drug-resistant epilepsy so doctors can plan more accurate treatments.
This trial uses a type of eye scan (OCT) to look at the retina in people with brain conditions like multiple sclerosis, Alzheimer's, Parkinson's, or migraines. It aims to see if these scans can help doctors learn more about the disease and monitor it over time.
This study uses a special eye scan (OCTA) to check the health of tiny blood vessels in the back of the eye. It may help doctors understand small vessel disease in the brain and find easier ways to monitor it.
Hear when a new Epilepsy (Treatment Refractory) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.